These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 20873842)

  • 21. Matched Molecular Pair Analysis in Short: Algorithms, Applications and Limitations.
    Tyrchan C; Evertsson E
    Comput Struct Biotechnol J; 2017; 15():86-90. PubMed ID: 28066532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Compilation and physicochemical classification analysis of a diverse hERG inhibition database.
    Didziapetris R; Lanevskij K
    J Comput Aided Mol Des; 2016 Dec; 30(12):1175-1188. PubMed ID: 27783199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting the relative binding affinity of mineralocorticoid receptor antagonists by density functional methods.
    Roos K; Hogner A; Ogg D; Packer MJ; Hansson E; Granberg KL; Evertsson E; Nordqvist A
    J Comput Aided Mol Des; 2015 Dec; 29(12):1109-22. PubMed ID: 26572910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Matched Peptides: Tuning Matched Molecular Pair Analysis for Biopharmaceutical Applications.
    Fuchs JE; Wellenzohn B; Weskamp N; Liedl KR
    J Chem Inf Model; 2015 Nov; 55(11):2315-23. PubMed ID: 26501781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A 'rule of 0.5' for the metabolite-likeness of approved pharmaceutical drugs.
    O Hagan S; Swainston N; Handl J; Kell DB
    Metabolomics; 2015; 11(2):323-339. PubMed ID: 25750602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Global analysis reveals families of chemical motifs enriched for HERG inhibitors.
    Du F; Babcock JJ; Yu H; Zou B; Li M
    PLoS One; 2015; 10(2):e0118324. PubMed ID: 25700001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted kinase selectivity from kinase profiling data.
    Milletti F; Hermann JC
    ACS Med Chem Lett; 2012 May; 3(5):383-6. PubMed ID: 24900482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemical transformations that yield compounds with distinct activity profiles.
    Hu Y; Bajorath J
    ACS Med Chem Lett; 2011 Jul; 2(7):523-7. PubMed ID: 24900343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Limits to molecular matched-pair analysis: the experimental uncertainty case.
    Kramer C; Liedl K
    J Cheminform; 2014 Mar; 6(Suppl 1):O6. PubMed ID: 24765129
    [No Abstract]   [Full Text] [Related]  

  • 30. Using matched molecular series as a predictive tool to optimize biological activity.
    O'Boyle NM; Boström J; Sayle RA; Gill A
    J Med Chem; 2014 Mar; 57(6):2704-13. PubMed ID: 24601597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemical predictive modelling to improve compound quality.
    Cumming JG; Davis AM; Muresan S; Haeberlein M; Chen H
    Nat Rev Drug Discov; 2013 Dec; 12(12):948-62. PubMed ID: 24287782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A fingerprint pair analysis of hERG inhibition data.
    Springer C; Sokolnicki KL
    Chem Cent J; 2013 Oct; 7(1):167. PubMed ID: 24144230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Automated molecule editing in molecular design.
    Kenny PW; Montanari CA; Prokopczyk IM; Sala FA; Sartori GR
    J Comput Aided Mol Des; 2013 Aug; 27(8):655-64. PubMed ID: 24002455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. QSAR model based on weighted MCS trees approach for the representation of molecule data sets.
    Palacios-Bejarano B; Cerruela García G; Luque Ruiz I; Gómez-Nieto MÁ
    J Comput Aided Mol Des; 2013 Feb; 27(2):185-201. PubMed ID: 23386139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SwissBioisostere: a database of molecular replacements for ligand design.
    Wirth M; Zoete V; Michielin O; Sauer WH
    Nucleic Acids Res; 2013 Jan; 41(Database issue):D1137-43. PubMed ID: 23161688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac Safety Implications of hNav1.5 Blockade and a Framework for Pre-Clinical Evaluation.
    Erdemli G; Kim AM; Ju H; Springer C; Penland RC; Hoffmann PK
    Front Pharmacol; 2012; 3():6. PubMed ID: 22303294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ChEMBL: a large-scale bioactivity database for drug discovery.
    Gaulton A; Bellis LJ; Bento AP; Chambers J; Davies M; Hersey A; Light Y; McGlinchey S; Michalovich D; Al-Lazikani B; Overington JP
    Nucleic Acids Res; 2012 Jan; 40(Database issue):D1100-7. PubMed ID: 21948594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lead optimization using matched molecular pairs: inclusion of contextual information for enhanced prediction of HERG inhibition, solubility, and lipophilicity.
    Papadatos G; Alkarouri M; Gillet VJ; Willett P; Kadirkamanathan V; Luscombe CN; Bravi G; Richmond NJ; Pickett SD; Hussain J; Pritchard JM; Cooper AW; Macdonald SJ
    J Chem Inf Model; 2010 Oct; 50(10):1872-86. PubMed ID: 20873842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Side chain flexibilities in the human ether-a-go-go related gene potassium channel (hERG) together with matched-pair binding studies suggest a new binding mode for channel blockers.
    Zachariae U; Giordanetto F; Leach AG
    J Med Chem; 2009 Jul; 52(14):4266-76. PubMed ID: 19534531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of hERG channel blockers using a decision tree.
    Gepp MM; Hutter MC
    Bioorg Med Chem; 2006 Aug; 14(15):5325-32. PubMed ID: 16616507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.